search
European Medicines Agency
Trends
- 1Women are missing from medicines development, EMA says▼Women are missing from medicines development: EMA’s roadmap for change
The European Medicines Agency has published a roadmap to address the underrepresentation of women in medicines development, from clinical trial participation to research design. The agency says data on how medicines work in women has long been insufficient, and it is setting out measures to improve evidence and health outcomes for female patients across the EU.